TNF- antagonists: monoclonal antibodies, soluble receptors, thalidomide and other novel approaches

ISSN： 1354-3784

Source： Expert Opinion on Investigational Drugs, Vol.6, Iss.8, 1997-08, pp. : 1105-1108

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Monoclonal Antibodies as Pharmacokinetic Antagonists for the Treatment of (+)-Methamphetamine Addiction

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 10, Iss. 8, 2011-12 ,pp. : 892-898

Bentham Science Publishers

Access to resources Recommend Favorite

Novel Approaches for Identification of Broadly Cross-Reactive HIV-1 Neutralizing Human Monoclonal Antibodies and Improvement of Their Potency

Current Pharmaceutical Design, Vol. 13, Iss. 2, 2007-01 ,pp. : 203-212

Bentham Science Publishers

Access to resources Recommend Favorite

Monoclonal anti-TNF antibodies may increase risk of herpes zoster

Reactions Weekly, Vol. 1, Iss. 1241, 2009-01 ,pp. : 5-5

Adis International

Access to resources Recommend Favorite

Novel Monoclonal Antibodies for the Treatment of Chronic Lymphocytic Leukemia

Current Cancer Drug Targets, Vol. 8, Iss. 2, 2008-03 ,pp. : 156-171

Bentham Science Publishers

Access to resources Recommend Favorite

Kinin Receptors and Their Antagonists as Novel Therapeutic Agents

Current Pharmaceutical Design, Vol. 7, Iss. 2, 2001-01 ,pp. : 135-161

Bentham Science Publishers

Access to resources Recommend Favorite